These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 15748162)
1. Inhibition of microglial inflammation by the MLK inhibitor CEP-1347. Lund S; Porzgen P; Mortensen AL; Hasseldam H; Bozyczko-Coyne D; Morath S; Hartung T; Bianchi M; Ghezzi P; Bsibsi M; Dijkstra S; Leist M J Neurochem; 2005 Mar; 92(6):1439-51. PubMed ID: 15748162 [TBL] [Abstract][Full Text] [Related]
2. CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-alpha release from lipopolysaccharide-treated cells and mice. Ciallella JR; Saporito M; Lund S; Leist M; Hasseldam H; McGann N; Smith CS; Bozyczko-Coyne D; Flood DG Eur J Pharmacol; 2005 May; 515(1-3):179-87. PubMed ID: 15904918 [TBL] [Abstract][Full Text] [Related]
3. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188 [TBL] [Abstract][Full Text] [Related]
4. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways. Lee DY; Oh YJ; Jin BK Glia; 2005 Aug; 51(2):98-110. PubMed ID: 15789435 [TBL] [Abstract][Full Text] [Related]
6. Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival. Wang LH; Paden AJ; Johnson EM J Pharmacol Exp Ther; 2005 Mar; 312(3):1007-19. PubMed ID: 15525794 [TBL] [Abstract][Full Text] [Related]
7. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia. Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113 [TBL] [Abstract][Full Text] [Related]
8. Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Akundi RS; Candelario-Jalil E; Hess S; Hüll M; Lieb K; Gebicke-Haerter PJ; Fiebich BL Glia; 2005 Aug; 51(3):199-208. PubMed ID: 15800925 [TBL] [Abstract][Full Text] [Related]
9. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Qin L; Li G; Qian X; Liu Y; Wu X; Liu B; Hong JS; Block ML Glia; 2005 Oct; 52(1):78-84. PubMed ID: 15920727 [TBL] [Abstract][Full Text] [Related]
10. Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347. Falsig J; Pörzgen P; Lotharius J; Leist M J Immunol; 2004 Aug; 173(4):2762-70. PubMed ID: 15294995 [TBL] [Abstract][Full Text] [Related]
11. c-Jun N-terminal kinase and p38 mitogen-activated protein kinase mediate double-strand RNA-induced inducible nitric oxide synthase expression in microglial cells. Kong PJ; Lee HJ; Lee SH; Kim SY; Lee SN; Chun WJ; Kim SS Neurosci Lett; 2008 Mar; 433(3):215-8. PubMed ID: 18258363 [TBL] [Abstract][Full Text] [Related]
13. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. Suzuki T; Hide I; Matsubara A; Hama C; Harada K; Miyano K; Andrä M; Matsubayashi H; Sakai N; Kohsaka S; Inoue K; Nakata Y J Neurosci Res; 2006 Jun; 83(8):1461-70. PubMed ID: 16652343 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia. Ejarque-Ortiz A; Medina MG; Tusell JM; Pérez-González AP; Serratosa J; Saura J Glia; 2007 Jan; 55(2):178-88. PubMed ID: 17078024 [TBL] [Abstract][Full Text] [Related]
15. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia. Zhou Y; Ling EA; Dheen ST J Neurochem; 2007 Aug; 102(3):667-78. PubMed ID: 17403137 [TBL] [Abstract][Full Text] [Related]
16. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344 [TBL] [Abstract][Full Text] [Related]
17. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715 [TBL] [Abstract][Full Text] [Related]
18. Effects of human marrow stromal cells on activation of microglial cells and production of inflammatory factors induced by lipopolysaccharide. Zhou C; Zhang C; Chi S; Xu Y; Teng J; Wang H; Song Y; Zhao R Brain Res; 2009 May; 1269():23-30. PubMed ID: 19269277 [TBL] [Abstract][Full Text] [Related]
19. Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation. Kwak HJ; Song JS; Heo JY; Yang SD; Nam JY; Cheon HG J Pharmacol Exp Ther; 2005 Dec; 315(3):1188-95. PubMed ID: 16126838 [TBL] [Abstract][Full Text] [Related]
20. Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release. Gomez-Nicola D; Valle-Argos B; Nieto-Sampedro M Glia; 2010 Feb; 58(3):264-76. PubMed ID: 19610094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]